ID: ALA5284675

Max Phase: Preclinical

Molecular Formula: C33H54N10O13

Molecular Weight: 798.85

Associated Items:

Representations

Canonical SMILES:  CC(C)[C@H](NC(=O)N[C@H](C(=O)N[C@H](C(=O)NCCCN[C@@H](CC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@H](O)[C@@H]1O)C(=O)O)[C@@H](O)C(C)C)[C@@H]1CCNC(=N)N1)C(=O)O

Standard InChI:  InChI=1S/C33H54N10O13/c1-14(2)20(30(52)53)41-32(54)42-21(16-8-12-37-31(34)38-16)27(49)40-22(23(45)15(3)4)26(48)36-11-5-10-35-17(29(50)51)6-7-18-24(46)25(47)28(56-18)43-13-9-19(44)39-33(43)55/h9,13-18,20-25,28,35,45-47H,5-8,10-12H2,1-4H3,(H,36,48)(H,40,49)(H,50,51)(H,52,53)(H3,34,37,38)(H,39,44,55)(H2,41,42,54)/t16-,17-,18+,20-,21-,22-,23-,24+,25+,28+/m0/s1

Standard InChI Key:  BLSOKIUKJKZSLZ-TZAJGVHHSA-N

Associated Targets(non-human)

Phospho-N-acetylmuramoyl-pentapeptide-transferase 27 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 798.85Molecular Weight (Monoisotopic): 798.3872AlogP: -4.35#Rotatable Bonds: 20
Polar Surface Area: 358.65Molecular Species: ZWITTERIONHBA: 14HBD: 14
#RO5 Violations: 3HBA (Lipinski): 23HBD (Lipinski): 14#RO5 Violations (Lipinski): 3
CX Acidic pKa: 2.84CX Basic pKa: 25.54CX LogP: -8.11CX LogD: -8.11
Aromatic Rings: 1Heavy Atoms: 56QED Weighted: 0.06Np Likeness Score: 0.60

References

1. Serpi M, Ferrari V, Pertusati F..  (2016)  Nucleoside Derived Antibiotics to Fight Microbial Drug Resistance: New Utilities for an Established Class of Drugs?,  59  (23): [PMID:27607900] [10.1021/acs.jmedchem.6b00325]

Source